About Biodesix, Inc.
https://www.biodesix.comBiodesix, Inc. operates as a data-driven diagnostic solutions company in the United States.
CEO
Scott Hutton
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-09-15 | Reverse | 1:20 |
ETFs Holding This Stock
Summary
Showing Top 1 of 11
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Canaccord Genuity
Buy
Craig-Hallum
Buy
Lake Street
Buy
Scotiabank
Sector Outperform
William Blair
Market Perform
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:415.91K
Value:$3.75M
TELEMARK ASSET MANAGEMENT, LLC
Shares:414.12K
Value:$3.74M
BIRCHVIEW CAPITAL, LP
Shares:286.8K
Value:$2.59M
Summary
Showing Top 3 of 17
About Biodesix, Inc.
https://www.biodesix.comBiodesix, Inc. operates as a data-driven diagnostic solutions company in the United States.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $21.77M ▲ | $24.71M ▼ | $-8.72M ▲ | -40.04% ▲ | $-1.16 ▲ | $-5.24M ▲ |
| Q2-2025 | $20.02M ▲ | $25.71M ▲ | $-11.47M ▼ | -57.29% ▲ | $-1.6 | $-8.16M ▼ |
| Q1-2025 | $17.96M ▼ | $23.39M ▲ | $-11.1M ▼ | -61.82% ▼ | $-1.6 ▼ | $-8.01M ▼ |
| Q4-2024 | $20.43M ▲ | $22.74M ▲ | $-8.25M ▲ | -40.39% ▲ | $-1.2 ▲ | $-5.1M ▲ |
| Q3-2024 | $18.15M | $22.56M | $-10.26M | -56.51% | $-1.4 | $-6.8M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $16.7M ▼ | $88.72M ▲ | $90.44M ▲ | $-1.72M ▼ |
| Q2-2025 | $20.73M ▲ | $87.74M ▲ | $86.6M ▲ | $1.14M ▼ |
| Q1-2025 | $17.6M ▼ | $86.24M ▼ | $75.18M ▼ | $11.06M ▼ |
| Q4-2024 | $26.25M ▼ | $97.24M ▼ | $76.37M ▲ | $20.88M ▼ |
| Q3-2024 | $31.41M | $102.74M | $74.89M | $27.86M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-8.72M ▲ | $-8.88M ▼ | $-67K ▲ | $4.82M ▼ | $-4.12M ▼ | $-8.93M ▼ |
| Q2-2025 | $-11.47M ▼ | $-6.57M ▲ | $-95K ▲ | $9.79M ▲ | $3.13M ▲ | $-6.62M ▲ |
| Q1-2025 | $-11.1M ▼ | $-8.6M ▼ | $-137K ▲ | $97K ▲ | $-8.64M ▼ | $-8.74M ▼ |
| Q4-2024 | $-8.25M ▲ | $-4.1M ▲ | $-884K ▼ | $-181K ▼ | $-5.16M ▲ | $-4.98M ▲ |
| Q3-2024 | $-10.26M | $-10.67M | $-286K | $144K | $-10.81M | $-10.96M |
Revenue by Products
| Product | Q3-2024 | Q2-2025 | Q1-2025 | Q3-2025 |
|---|---|---|---|---|
 Development Services | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Diagnostic Tests | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
CEO
Scott Hutton
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-09-15 | Reverse | 1:20 |
ETFs Holding This Stock
Summary
Showing Top 1 of 11
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Canaccord Genuity
Buy
Craig-Hallum
Buy
Lake Street
Buy
Scotiabank
Sector Outperform
William Blair
Market Perform
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:415.91K
Value:$3.75M
TELEMARK ASSET MANAGEMENT, LLC
Shares:414.12K
Value:$3.74M
BIRCHVIEW CAPITAL, LP
Shares:286.8K
Value:$2.59M
Summary
Showing Top 3 of 17